HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

Hibiki Udagawa, Monique B. Nilsson, Jacqulyne Robichaux, Junqin He, Alissa Poteete, Hong Jiang, Simon Heeke, Yasir Y. Elamin, Yuji Shibata, Shingo Matsumoto, Kiyotaka Yoh, Shogo Okazaki, Takashi Masuko, Igor Odintsov, Romel Somwar, Marc Ladanyi, Kōichi Goto, John V. Heymach